Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092)

Vincenzo Valentini, Maria Antonietta Gambacorta, Carlo Ratto, Brunella Barbaro, Giovanna Mantini, Fabio Maria Vecchio, Concettina Rossi, Maria Cristina Barba, Alessandro Frattegiani, Giovanni Doglietto, A De Paoli, R Innocente, G Boz, M Lupattelli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

53 Citazioni (Scopus)

Abstract

To report the final data of a Phase I and II study (1839IL/0092) on the combination of an anti-epidermal growth factor receptor drug (gefitinib), infusional 5-fluorouracil, and preoperative radiotherapy in locally advanced, resectable rectal cancer.
Lingua originaleEnglish
pagine (da-a)644-649
Numero di pagine6
RivistaInternational Journal of Radiation Oncology Biology Physics
Volume72
DOI
Stato di pubblicazionePubblicato - 2008

Keywords

  • Advanced Rectal Cancer
  • Preoperative chemioradiotherapy

Fingerprint

Entra nei temi di ricerca di 'Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092)'. Insieme formano una fingerprint unica.

Cita questo